AnalystBook Research · Company Intelligence

BIOLIFE SOLUTIONS INC

BLFSNasdaq

Built from BIOLIFE SOLUTIONS INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

BioLife improved net loss, cash flow, debt, and equity, but insider sales and a wider operating loss kept the FY2025 read mixed.

The read at a glance✓ Audited against SEC data
  • Business mixBioproduction toolsNote
  • Gross profitGross profit up to $62.1MOK
  • LossNet loss narrowed 77.2%OK
  • FCFFCF up to $10.6MOK
  • DebtDebt down 68.7%OK
  • Insiders0 purchases / 63 salesWatch
  • AccountingForensic screens unavailableNote

Business

BioLife Solutions provides bioproduction products and services used in biologic material manufacturing and delivery, with a focus on biopreservation media and cell-processing products.

Where the revenue comes from

Fiscal 2024, as BIOLIFE SOLUTIONS INC reports it. History and quarterly detail are in the app.

  • Product$76.0M
  • Product Cell Processing$73.4M
  • Rental Revenue$6.1M
  • Rental Evo And Thaw$6.1M
  • Product Evo And Thaw$2.6M

Leadership changes

From BIOLIFE SOLUTIONS INC's own filings, the day they're filed.

  • Catherine Coste · directors · departureeff. 2025-03-18
  • Tony J. Hunt · Chairman · appointmenteff. 2025-01-02

Latest filings

  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-08-06
  • 8-K · Company announcement2026-08-03
  • 8-K · Company announcement2026-07-22
  • 8-K · Company announcement2026-06-03
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about BIOLIFE SOLUTIONS INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.